ARCHIVES

By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure

This article is from The Cancer Letter archive.

Vol. 36 No. 28 | July 23, 2010

Download PDF Visit The Full Archive

Related Articles

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Management Information Contract Recompetition Approved By Committee

February 15, 1985

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

NCI-Approved Clinical Trials

October 29, 2004

Concepts for New, Recompeted DCCP Contracts Approved

June 12, 1981